Q32 Bio Q3 2024 GAAP EPS $(1.46) Misses $(1.31) Estimate, Cash And Cash Equivalents Of $89.1M As Of September 30, 2024 Expected To Provide Financial Runway Into Mid-2026

Benzinga · Nov 7, 2024 12:23

Q32 Bio (NASDAQ:QTTB) reported quarterly losses of $(1.46) per share which missed the analyst consensus estimate of $(1.31) by 11.45 percent.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

Recommended

Despite the adjustment of the US stock market, individual investors are increasing their positions against the trend! Tesla…

wallstreetcn · Mar 14, 2025 07:45
Report: Tesla will launch a "Low Stock Price" version of the Model Y next year, reducing costs by 20% to defend its market share i…

wallstreetcn · Mar 14, 2025 10:24
The new bond king: Gold prices are expected to surge towards 4,000 dollars, and the possibility of a recession in the USA this y…

wallstreetcn · Mar 14, 2025 11:20
The "East rises and West sets" continues! Wall Street complains: Trump is making China stocks great again.

cls.cn · Mar 14, 2025 07:28
What to watch at NVIDIA GTC next week? Blackwell, Rubin, CPO, Siasun Robot&Automation....

wallstreetcn · Mar 14, 2025 08:46

Write a comment

Q32 Bio Q3 2024 GAAP EPS $(1.46) Misses $(1.31) Estimate, Cash And Cash Equivalents Of $89.1M As Of September 30, 2024 Expected To Provide Financial Runway Into Mid-2026

Risk Disclaimer